BIOL (BIOLASE, Inc.) Total Enterprise Value

BIOL (Biolase Inc.) - company brandmark

BIOLASE, Inc. (BIOL) management possesses significant technical expertise in the dental laser niche, overcoming mass market inertia. The company generates revenue through the creation of systems for gum therapy and tooth treatment, as well as through ancillary services. This chart demonstrates an Enterprise Value of . Business growth relies on the pace of clinic digitalization, while a sufficient liquidity cushion mitigates the risks associated with lengthy deal cycles.

BIOL (Biolase, Inc.) Total Company Value history from 07/04/2022 to 10/28/2026

Financial and market metric breakdowns for BIOLASE, Inc. (BIOL)

- price and consensus price forecast:
Market Chart BIOLASE Inc.|BIOL - Price Target Chart
- market capitalization data:
Market Value BIOLASE|BIOL - Total Company Value
- book capitalization data:
Net Assets per Single Share BIOLASE|BIOL - Company Book Value|Market Capitalization to Book Value biolase.com|BIOL - Aggregate Company Assets
- debt and liquidity data:
Aggregate Debt to Equity BIOLASE, Inc.|BIOL - Long-Term Debt to Capital|Current Liabilities to Capital biolase.com|BIOL - Company Aggregate Debts|Debt to Book Value BIOLASE
Fundamental company valuation:BIOL (BIOLASE Inc.)
Original product of Biolase, Inc.

Enterprise value serves as a key filter for asset stress-testing, allowing for the determination of a fair buyout price by combining market capitalization and net debt. By analyzing the enterprise value chart, an investor can discern the real demand for BIOLASE, Inc. (BIOL) amid the fierce competition for dental clinic budgets against medtech behemoths, which helps avoid overpaying for the company's market share.

Competing companies

Boston Scientific Corp - Company Buyout Price|EW (Edwards Lifesciences Corp) - Total Company Value|RMD: Total Enterprise Value|Insulet Corporation (PODD) - Total Company Value|ZBH (Zimmer Biomet Holdings) - Total Company Value|COO: Total Company Value|Company Buyout Price ALGN|GMED - Total Company Value|Full Business Value TransMedics Group Inc (TMDX)|ATEC: Enterprise Value|Total Enterprise Value artivion.com AORT|ENOV: Enterprise Value|IART - Real Price to Acquire Entire Company|Motiva - Enterprise Value|iLet Bionic Pancreas (BBNX) - Company Buyout Price|IRMD (IRADIMED CORPORATION) - Enterprise Value|Enterprise Value EMBC|Total Company Value Tandem Diabetes Care, Inc. (TNDM)|Total Company Value AxoGen Inc (AXGN)|Enterprise Value SIBN|OFIX - Company Buyout Price|Real Price to Acquire Entire Company Bioventus Inc.|KIDS - Full Business Value|Enterprise Value TMCI|Blade Air Mobility (SRTA) - Total Enterprise Value|Enterprise Value Carlsmed Corp (CARL)|Business Value RxSight Ophthalmic (RXST)|ClearPoint Neuro, Inc. (CLPT) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash STXS (stereotaxis.com)|Neuronetics - Total Company Value|Real Price to Acquire Entire Company Sight Sciences Inc. SGHT|OBIO (Orchestra BioMed, Inc.) - Enterprise Value|ANIK - Total Enterprise Value|Enterprise Value InspireMD, Inc.|Jin Medical (ZJYL) - Business Value|VANI: Enterprise Value|Company Buyout Price Xtant Medical Inc|Enterprise Value NMTC (NeuroOne Corp)|Real Price to Acquire Entire Company modular-medical.com (MODD)|Enterprise Value MYO (Myomo, Inc.)|envoymedical.com - Enterprise Value|VVOS - Total Company Value|enVVeno Medical Corporation (NVNO) - Total Company Value|Real Price to Acquire Entire Company sintx.com SINT|Tenon Medical Inc (TNON) - Value Adjusted for Debt and Cash|Enterprise Value LFWD (ReWalk Robotics Ltd.)|Total Enterprise Value AMIX|IVF: Total Company Value|Full Takeover Company Value Bone Biologics Corp. BBLG|Real Price to Acquire Entire Company AXNX (Axonics Modulation Technologies)|Enterprise Value Dynatronics Corp DYNT|Enterprise Value FNA (Paragon 28 Corp)|INVO: Company Buyout Price